Jeremy Robert Burt

Jeremy Robert Burt

Auto-generated profile, based on publicly available information

Jeremy Robert Burt

Radiology, The University of Utah, Salt Lake City, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2021 in BMC Medicine
Verified
Journal Article
Open access
PDF file
JCJordan Chamberlin
Jordan Chamberlin
MKMadison R. Kocher
Madison R. Kocher
JWJeffrey Waltz
Jeffrey Waltz
MSMadalyn Snoddy
Madalyn Snoddy
NSNatalie F. C. Stringer
Natalie F. C. Stringer
JBJeremy R. Burt
Jeremy R. Burt
Background: Artificial intelligence (AI) in diagnostic radiology is undergoing rapid development. Its potential utility to improve diagnostic performance for cardiopulmonary events is widely recognized, but the accuracy and precision have yet to be demonstrated in the context of current screening modalities. Here, we present findings on the performance of an AI convolutional neural network (CNN) prototype (AI-RAD Companion, Siemens Healthineers) that automatically detects pulmonary nodules and quantifies coronary artery calcium volume (CACV) on low-dose chest CT (LDCT), and compare results to expert radiologists. We also correlate AI findings with adverse cardiopulmonary outcomes in a retrospective cohort of 117 patients who underwent LDCT. Methods: A total of 117 patients were enrolled in this study. Two CNNs were used to identify lung nodules and CACV on LDCT scans. All subjects were used for lung nodule analysis, and 96 subjects met the criteria for coronary artery calcium volume analysis. Interobserver concordance was measured using ICC and Cohen’s kappa. Multivariate logistic regression and partial least squares regression were used for outcomes analysis. Results: Agreement of the AI findings with experts was excellent (CACV ICC = 0.904, lung nodules Cohen’s kappa = 0.846) with high sensitivity and specificity (CACV: sensitivity = .929, specificity = .960; lung nodules: sensitivity = 1, specificity = 0.708). The AI findings improved the prediction of major cardiopulmonary outcomes at 1-year follow-up including major adverse cardiac events and lung cancer (AUCMACE = 0.911, AUCLung Cancer = 0.942). Conclusion: We conclude the AI prototype rapidly and accurately identifies significant risk factors for cardiopulmonary disease on standard screening low-dose chest CT. This information can be used to improve diagnostic ability, facilitate intervention, improve morbidity and mortality, and decrease healthcare costs. There is also potential application in countries with limited numbers of cardiothoracic radiologists.

10 April 2018 in British Journal of Radiology
Verified
Journal Article
Closed access
JBJeremy R Burt
Jeremy R Burt
NTNeslisah Torosdagli
Neslisah Torosdagli
NKNaji Khosravan
Naji Khosravan
HRHarish RaviPrakash
Harish RaviPrakash
AMAliasghar Mortazi
Aliasghar Mortazi
UBUlas Bagci
Ulas Bagci
Deep learning has demonstrated tremendous revolutionary changes in the computing industry and its effects in radiology and imaging sciences have begun to dramatically change screening paradigms. Sp...

1 November 2013 in JACC
Verified
Journal Article
Closed access
ARAnneline S. J. M. Te Riele
Anneline S. J. M. Te Riele
ABAditya Bhonsale
Aditya Bhonsale
CJCynthia A. James
Cynthia A. James
NRNeda Rastegar
Neda Rastegar
BMBrittney Murray
Brittney Murray
HTHarikrishna Tandri
Harikrishna Tandri

15 June 2022 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
AAAli M. Agha
Ali M. Agha
JPJustin Pacor
Justin Pacor
GGGowtham R. Grandhi
Gowtham R. Grandhi
RMReed Mszar
Reed Mszar
SKSafi U. Khan
Safi U. Khan
KNKhurram Nasir
Khurram Nasir

1 March 2014 in RadioGraphics
Verified
Journal Article
Closed access
JBJeremy R. Burt
Jeremy R. Burt
SZStefan L. Zimmerman
Stefan L. Zimmerman
IKIhab R. Kamel
Ihab R. Kamel
MHMarc Halushka
Marc Halushka
DBDavid A. Bluemke
David A. Bluemke
Myocardial T1 mapping has the potential to noninvasively identify diffusely fibrotic myocardium that is associated with ischemic and nonischemic cardiomyopathy. Myocardial fibrosis is a common endpoint in a variety of cardiac diseases and a major independent predictor of adverse cardiac outcomes. Short of histopathologic analysis, which is limited by sampl...

1 October 2014 in RadioGraphics
Verified
Journal Article
Closed access
NRNeda Rastegar
Neda Rastegar
JBJeremy R. Burt
Jeremy R. Burt
CCCelia P. Corona-Villalobos
Celia P. Corona-Villalobos
ARAnneline S. Te Riele
Anneline S. Te Riele
CJCynthia A. James
Cynthia A. James
IKIhab R. Kamel
Ihab R. Kamel
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a familial cardiomyopathy characterized by fibrofatty replacement of the myocardium, ventricular tachycardia, and ventricular dysfunction that affects primarily the right ventricle (RV). This disease is not common but can be seen more frequently in young adults, and clinical manifestations range from no symptoms to lethal arrhythmia and sudden death. The diagnosis of ARVC is challenging and is based on the recently revised international task force criteria. Given the strengths of cardiac magnetic resonance (MR) imaging for depicting the RV, this modality plays an important role in the diagnosis of ARVC. Functional and structural abnormalities of the RV depicted with cardiac MR imaging constitute major and minor criteria in the revised task force criteria. Since the ARVC program was established at our center in 1998, there has been an increased awareness of a number of normal variants that are commonly misinterpreted as showing evidence for ARVC. On the basis of our clinical experience, the overdiagnosis of ARVC appears to reflect two fundamental problems: (a) a lack of awareness of diagnostic criteria that identify major and minor variables to be used for the diagnosis of ARVC, and (b) a lack of familiarity with the normal variants and mimics that may be misinterpreted as showing evidence of ARVC. The purpose of this article is to review the typical patterns of ventricular involvement in ARVC at cardiac MR imaging and to compare those with the patterns of normal variants and other diseases that can mimic ARVC. Online supplemental material is available for this article.